Effects of pharmacological modulation of cortical excitability on resting-state EEG PAC in humans
Abstract
Electroencephalography (EEG) signal is driven by oscillations arising from the synchronized activity of cortical neuronal populations. Phase-amplitude coupling (PAC) refers to the interaction whereby the amplitude of higher-frequency oscillations is systematically modulated by the phase of slower rhythms. It has been suggested that the excitation/inhibition (E/I) balance, which is often disrupted in neuropsychiatric and neurodegenerative disorders, plays a critical role in shaping PAC, although direct evidence in humans remains limited. In this study, we investigated the effects of pharmacologically modulated E/I balance on PAC using resting-state EEG (rs-EEG) data. Specifically, we analyzed the impact of anti-glutamatergic drugs, dextromethorphan (NMDA receptor antagonist) and perampanel (AMPA receptor antagonist), as well as nimodipine (L-type voltage-gated calcium channel blocker) on PAC in a double blind, placebo-controlled experiment. Analysis revealed a significant decrease in PAC following administration of dextromethorphan and perampanel, while nimodipine and placebo showed no effects. By showing that PAC is sensitive to pharmacological modulation consistent with shifts in cortical E/I balance, this study confirms its physiological relevance and supports its use as a biomarker of excitability disturbances and cortical dysfunction across neurological and psychiatric disorders.
Related
- Regional and network-level resting state functional connectivity markers of pharmacological treatment resistance in obsessive-compulsive disorder
- Matching Corticospinal and Cortical Excitability along the motor cortex: TMS-EMG-EEG study
- CREST: A Cortical Resting-State EEG Spatial Transformer for Chronic Pain Inference
- Pharmacological BET Protein Inhibition Reverts Niemann-Pick Type C Disease-Associated Changes in Human iPSC-Derived Cortical Neurons
- Neural encoding of grasp and object properties in the posterior parietal and motor cortices of the cortical grasping network in tetraplegic humans
BibTeX
@article{er2026effects,
title = {{Effects of pharmacological modulation of cortical excitability on resting-state EEG PAC in humans}},
author = {Alper Er and Paolo Belardinelli and Véronique Marchand-Pauvert and Ulf Ziemann and Guillaume Marrelec},
journal = {Scientific Reports},
year = {2026},
month = jun,
doi = {10.1038/s41598-026-55712-5},
url = {https://hal.science/hal-05667274v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Effects of pharmacological modulation of cortical excitability on resting-state EEG PAC in humans
AU - Alper Er
AU - Paolo Belardinelli
AU - Véronique Marchand-Pauvert
AU - Ulf Ziemann
AU - Guillaume Marrelec
PY - 2026
DA - 2026/06/16
JO - Scientific Reports
DO - 10.1038/s41598-026-55712-5
UR - https://hal.science/hal-05667274v1
AB - Electroencephalography (EEG) signal is driven by oscillations arising from the synchronized activity of cortical neuronal populations. Phase-amplitude coupling (PAC) refers to the interaction whereby the amplitude of higher-frequency oscillations is systematically modulated by the phase of slower rhythms. It has been suggested that the excitation/inhibition (E/I) balance, which is often disrupted in neuropsychiatric and neurodegenerative disorders, plays a critical role in shaping PAC, although direct evidence in humans remains limited. In this study, we investigated the effects of pharmacologically modulated E/I balance on PAC using resting-state EEG (rs-EEG) data. Specifically, we analyzed the impact of anti-glutamatergic drugs, dextromethorphan (NMDA receptor antagonist) and perampanel (AMPA receptor antagonist), as well as nimodipine (L-type voltage-gated calcium channel blocker) on PAC in a double blind, placebo-controlled experiment. Analysis revealed a significant decrease in PAC following administration of dextromethorphan and perampanel, while nimodipine and placebo showed no effects. By showing that PAC is sensitive to pharmacological modulation consistent with shifts in cortical E/I balance, this study confirms its physiological relevance and supports its use as a biomarker of excitability disturbances and cortical dysfunction across neurological and psychiatric disorders.
SN - 2045-2322
ER -